BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27311193)

  • 1. [Rheumatoid arthritis and viral hepatitis].
    Kobayashi H; Watanabe H; Ohira H
    Nihon Rinsho; 2016 Jun; 74(6):1007-11. PubMed ID: 27311193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hospital-Based Analysis in the Department of Clinical Chemistry for the Patients with HBV Reactivation after Anti-Cancer or Immunosuppressive Therapy.
    Matsuzaki T; Ohkubo K; Yuki M; Kawashima H; Matsunaga A
    Rinsho Byori; 2015 Mar; 63(3):297-304. PubMed ID: 26524851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
    Ahn SS; Jung SM; Song JJ; Park YB; Park JY; Lee SW
    Yonsei Med J; 2018 May; 59(3):452-456. PubMed ID: 29611409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.
    Ito S
    Mod Rheumatol; 2021 Jul; 31(4):775-782. PubMed ID: 33021133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Harigai M; Mochida S; Mimura T; Koike T; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):1-7. PubMed ID: 24261752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
    Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
    Mindikoglu AL; Regev A; Schiff ER
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.
    Tamori A; Hino M; Kawamura E; Fujii H; Uchida-Kobayashi S; Morikawa H; Nakamae H; Enomoto M; Murakami Y; Kawada N
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1715-21. PubMed ID: 24730465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.
    Biondo MI; Germano V; Pietrosanti M; Canzoni M; Marignani M; Stroffolini T; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jun; 25(5):482-4. PubMed ID: 24495663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Arthritis Res Ther; 2019 Nov; 21(1):255. PubMed ID: 31779676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
    Chen LF; Mo YQ; Jing J; Ma JD; Zheng DH; Dai L
    Int J Rheum Dis; 2017 Jul; 20(7):859-869. PubMed ID: 28160426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases.
    Kato M; Atsumi T; Kurita T; Odani T; Fujieda Y; Otomo K; Horita T; Yasuda S; Koike T
    J Rheumatol; 2011 Oct; 38(10):2209-14. PubMed ID: 21844146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate.
    Gwak GY; Koh KC; Kim HY
    Clin Exp Rheumatol; 2007; 25(6):888-9. PubMed ID: 18173926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of hepatitis B virus reactivation in a patient with prior resolved hepatitis B infection during bevacizumab plus FOLFIRI treatment].
    Noguchi Y; Tsurushima M; Tamura Y; Aoyama K; Tokuyama Y; Uchiyama K; Shimizu Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1561-3. PubMed ID: 24231716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus.
    Watanabe R; Ishii T; Harigae H
    Tohoku J Exp Med; 2015 Sep; 237(1):9-15. PubMed ID: 26288957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
    Fujita M; Sugiyama M; Sato Y; Nagashima K; Takahashi S; Mizokami M; Hata A
    J Viral Hepat; 2018 Nov; 25(11):1312-1320. PubMed ID: 29770539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.
    Mochida S; Nakao M; Nakayama N; Uchida Y; Nagoshi S; Ido A; Mimura T; Harigai M; Kaneko H; Kobayashi H; Tsuchida T; Suzuki H; Ura N; Nakamura Y; Bessho M; Dan K; Kusumoto S; Sasaki Y; Fujii H; Suzuki F; Ikeda K; Yamamoto K; Takikawa H; Tsubouchi H; Mizokami M
    J Gastroenterol; 2016 Oct; 51(10):999-1010. PubMed ID: 26831356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.
    Urata Y; Uesato R; Tanaka D; Kowatari K; Nitobe T; Nakamura Y; Motomura S
    Mod Rheumatol; 2011 Feb; 21(1):16-23. PubMed ID: 20668905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.